These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33245177)

  • 1. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.
    Lee DS; Meiser B; Mariapun S; Hassan T; Yip CH; Mohd Taib NA; Teo SH; Thong MK; Yoon SY
    J Genet Couns; 2021 Jun; 30(3):720-729. PubMed ID: 33245177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitated cascade testing (FaCT): a randomized controlled trial.
    Nitecki R; Moss HA; Watson CH; Urbauer DL; Melamed A; Lu KH; Lipkin SM; Offit K; Rauh-Hain JA; Frey MK
    Int J Gynecol Cancer; 2021 May; 31(5):779-783. PubMed ID: 33443030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives.
    Vos J; Menko F; Jansen AM; van Asperen CJ; Stiggelbout AM; Tibben A
    Fam Cancer; 2011 Mar; 10(1):87-96. PubMed ID: 20852944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
    Alegre N; Perre PV; Bignon YJ; Michel A; Galibert V; Mophawe O; Corsini C; Coupier I; Chiesa J; Robert L; Bernhard L; Picot MC; Bertet H; Macioce V; Bastide N; Solassol J; Rey JM; Thomas F; Carton S; Pujol P
    Psychooncology; 2019 Aug; 28(8):1679-1686. PubMed ID: 31152683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial communication and cascade testing among relatives of BRCA population screening participants.
    Lieberman S; Lahad A; Tomer A; Koka S; BenUziyahu M; Raz A; Levy-Lahad E
    Genet Med; 2018 Nov; 20(11):1446-1454. PubMed ID: 29595811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.
    Sanz J; Ramón y Cajal T; Torres A; Darder E; Gadea N; Velasco A; Fortuny D; López C; Fisas D; Brunet J; Alonso MC; Balmaña J
    Fam Cancer; 2010 Sep; 9(3):297-304. PubMed ID: 20091130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.
    O'Reilly DE; Dooley L; Watson GA; Clarke R; Nolan A; Nolan C; Berkeley E; Farrell M; McDevitt T; Rogers M; Clabby C; Gallagher DJ
    Ir J Med Sci; 2023 Aug; 192(4):1607-1611. PubMed ID: 36260241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
    Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
    BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
    Montgomery SV; Barsevick AM; Egleston BL; Bingler R; Ruth K; Miller SM; Malick J; Cescon TP; Daly MB
    Fam Cancer; 2013 Sep; 12(3):537-46. PubMed ID: 23420550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of BRCA1/2 cascade testing on anxiety, depression, and cancer worry levels among unaffected relatives in a multiethnic Asian cohort.
    Padmanabhan H; Mariapun S; Lee SY; Hassan NT; Lee DS; Meiser B; Wong SW; Lee YQ; Yip CH; Teo SH; Thong MK; Taib NAM; Yoon SY
    J Genet Couns; 2023 Feb; 32(1):43-56. PubMed ID: 35913122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study.
    Daly MB; Montgomery S; Bingler R; Ruth K
    Fam Cancer; 2016 Oct; 15(4):697-706. PubMed ID: 26897130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
    Seven M; Shah LL; Yazici H; Daack-Hirsch S
    Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives.
    Vlaming M; Ausems MGEM; Schijven G; van Oort IM; Kets CM; Komdeur FL; van der Kolk LE; Oldenburg RA; Sijmons RH; Kiemeney LALM; Bleiker EMA
    Fam Cancer; 2024 Jun; 23(2):165-175. PubMed ID: 38722431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.
    Fehniger J; Lin F; Beattie MS; Joseph G; Kaplan C
    J Genet Couns; 2013 Oct; 22(5):603-12. PubMed ID: 23666114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of Family-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with BRCA1 or BRCA2 Mutation.
    Jeong GW; Shin W; Lee DO; Seo SS; Kang S; Park SY; Lim MC
    Cancer Res Treat; 2021 Jan; 53(1):207-211. PubMed ID: 32777875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing in Poland and Ukraine: should comprehensive germline testing of
    Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A
    Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
    Hughes C; Lerman C; Schwartz M; Peshkin BN; Wenzel L; Narod S; Corio C; Tercyak KP; Hanna D; Isaacs C; Main D
    Am J Med Genet; 2002 Jan; 107(2):143-50. PubMed ID: 11807889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.